Author Interviews, COVID -19 Coronavirus, JAMA, Technology, UCSD, Vaccine Studies / 25.04.2024
UCSD Study Finds X’s Community Notes Fosters Learning Environment Rather Than Censorship Model
MedicalResearch.com Interview with:
John W. Ayers, PhD MA
Vice Chief of Innovation | Assoc. Professor
Div. Infectious Disease & Global Public Health University of California San Diego Since the World Health Organization declared an ‘infodemic’ of misinformation, there have been surprisingly few achievements to celebrate. X's Community Notes have emerged as an innovative strategy to address misinformation as reported in the latest issue of JAMA.
John W. Ayers, PhD MA
Vice Chief of Innovation | Assoc. ProfessorDiv. Infectious Disease & Global Public Health University of California San Diego Since the World Health Organization declared an ‘infodemic’ of misinformation, there have been surprisingly few achievements to celebrate. X's Community Notes have emerged as an innovative strategy to address misinformation as reported in the latest issue of JAMA.
Before the inception of Community Notes, social media companies employed various tactics to tackle misinformation, including censoring, shadowbanning (muting a user or their content on a platform without informing them), and adding generic warning labels to problematic content. However, these efforts were typically undisclosed meaning their effectiveness could not be studied.
In late 2022, X introduced Community Notes. This novel approach empowers volunteer, independent, anonymous, and ideologically diverse contributors to identify posts containing misinformation and to rectify misinformation by appending informative "notes" to suspect posts. The process is controlled by the public, instead of decision-makers at the company. Most importantly the system is open-sourced so it can be studied by external scientists.
LASIK is an excellent option for people who have to wear glasses or contacts and don't want to do that anymore. Before going in for a consultation, it's good to learn as much as possible about it. Here are some answers, including ones if you have
Amy Kennalley[/caption]
Amy Kennalley, MBS
First Year Medical Student
Department of Medical Education
Geisinger Commonwealth School of Medicine
MedicalResearch.com: What is the background for this study
Response: The legalization of medical marijuana (MMJ) and the number of qualifying conditions are expanding across the USA, emphasizing the need to understand the implications of MMJ dispensary distribution for equitable access. Pennsylvania (PA) legalized MMJ in 2016, with the first dispensary opening its doors in 2018. The state currently recognizes 24 medical conditions for MMJ use, including six for which there is insufficient or no evidence for their efficacy as a treatment. Prior research suggests that there is a link between proximity to dispensaries and overall MMJ use. However, a gap exists in our understanding of how dispensary locations might be associated with the specific qualifying conditions for which individuals receive their certification.
In response to this knowledge gap, our study delved into the medical marijuana dispensary access in PA and explored associations with both MMJ certifications and the community demographics. Utilizing data from the Pennsylvania Department of Health, we investigated how proximity to MMJ dispensaries related to the proportion of individuals certified for MMJ use within a specific area or Zip Code Tabulation Area. Additionally, we analyzed the proportion of certifications for conditions with varying levels of evidence supporting the efficacy of MMJ.
This pioneering study represents the first of its kind in PA, shedding light on the association between MMJ dispensary locations and certifications. Likewise, it is the first in the US to investigate the link between dispensary locations and specific qualifying conditions. By examining these dynamics, we aim to contribute vital insights to inform policy and practice, ensuring equitable access to MMJ treatment for individuals with diverse medical needs.
Dr. Tesi[/caption]
MedicalResearch.com Interview with:
RJ Tesi M.D.
CEO and Founder of

Dr. Solgama[/caption]
Jay P. Solgama
Medical Student
Department of Medical Education
Geisinger Commonwealth School of Medicine
Scranton PA
MedicalResearch.com: What is the background for this study?
Response: The opioid crisis in the United States continues to escalate, with opioid-related deaths increasing by over 800% since 2000. Prescription opioids, particularly oxycodone, have been a contributor to this crisis, with substantial variations in their distribution observed across different states [1,2,3].
Against this backdrop, the study conducted by researchers from the Geisinger Commonwealth School of Medicine aimed to characterize the distribution of oxycodone across US states from 2000 to 2021. By analyzing data from the Drug Enforcement Administration’s comprehensive Automation of Reports and Consolidated Orders System (ARCOS) and the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research (WONDER) databases, the study sought to identify trends and patterns in oxycodone distribution and their potential implications for opioid-related deaths [4,5].
Dr. Thomas Robert[/caption]
MedicalResearch.com Interview with:
Thomas Robert, MD, AIX
Associate Professor of Nephrology
APHM (Assistance Publique - Hopitaux de Marseille)
Marseille, Provence-Alpes-Côte d'Azur, France
[caption id="attachment_61498" align="alignleft" width="132"]
Dr. Letavernier[/caption]
Prof. Emmanuel Letavernier, MD PhD
Nephrologist at Tenon Hospital
Paris, France
MedicalResearch.com: What is the background for this study?
Response: Our work was prompted by emerging concerns surrounding the potential nephrotoxic effects of hair-straightening products containing glyoxylic acid. This inquiry was instigated by a patient who experienced three repeated acute episodes of kidney injury in June 2020, April 2021, and July 2022, each occurring shortly after a hair-straightening procedure. Notably, these episodes resolved with hydration.
Upon examining the composition of the hair product used by the patient, which contained glyoxylic acid, and considering the patient's report of painful ulcer scalp during application and subsequent scalp scarring, we suspected a potential link between exposure to glyoxylic acid and kidney injury. Consulting with my colleague, Professor Emmanuel Letavenier, a specialist in crystalline nephropathy at Paris, confirmed this suspicion.
In summer 2023, cases series have been reported by an Israeli team (
When you visit your doctor, you expect to receive accurate diagnoses and appropriate treatment. However, medical professionals can sometimes make mistakes that have serious consequences for patients. If you believe you have been the victim of a misdiagnosis in Virginia, you may be wondering about your legal options. Can you sue your doctor for a wrong diagnosis?
Consider the hypothetical case of Sarah, a hardworking professional plagued by persistent fatigue and headaches. After a series of tests with ambiguous results, her physician diagnoses her with chronic fatigue syndrome. Feeling a sense of relief at finally having an answer, Sarah diligently follows the recommended treatment plan and makes significant lifestyle changes. Despite her efforts, her health continues to deteriorate. Seeking a second opinion, Sarah discovers that she actually has a tumor which, while treatable, has gone undetected and caused substantial harm. Sarah's story illustrates the potentially devastating impact of a misdiagnosis, leaving her with both emotional trauma and severe medical issues.